Shares of Idea Cellular added 3 percent intraday Wednesday as research firm Deutsche Bank maintained buy on company with potential upside of 116.5 percent.
Research house keep a target of Rs 100 per share.
According to the firm, leverages are remain the key concern for the merge company.
It expect funding gap on a cash flow basis to be around Rs 7100 crore, while funding gap to increase net debt by Rs 3600 crore.
NCLT (National Company Law Tribunal) had approved the merger of Idea Cellular and the Indian unit of Vodafone Group Plc.
Idea Cellular shares declined 40 percent in the last 1 year.
At 11:12 hrs Idea Cellular was quoting at Rs 46.55, up Rs 0.35, or 0.76 percent on the BSE.
Disclaimer: The above report is compiled from information available on public platforms. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Top Financial Stocks For 2022: Tapestry, Inc.(TPR)
Tapestry, Inc. provides luxury accessories and branded lifestyle products in the United States, Japan, Greater China, Other Asia, and internationally. The company operates through three segments: Coach, Kate Spade, and Stuart Weitzman. The company offers women's accessories, including handbags, such as wallets, money pieces, wristlets, and cosmetic cases; novelty accessories comprising address books, time management and travel accessories, sketchbooks, and portfolios; and key rings and charms. It also provides bag collections, including business cases, computer bags, messenger-style bags, backpacks, and totes; small leather goods, such as wallets, card cases, travel organizers, and belts; and footwear, watches, sunglasses, novelty accessories, and ready-to-wear for men. In addition, the company offers women's footwear; sunglasses; bracelets, necklaces, rings, and earrings; fragrances and watches; women's seasonal lifestyle apparel collections that include outerwear and ready-to-wear, and cold weather accessories, which comprise gloves, scarves, and hats. Further, it provides ready-to-wear and footwear items for kids; fashion bedding and tableware; and stationery and gifts. Additionally, the company licenses rights to market and distribute its eyewear, watches, fragrances, and tech accessories under the Coach brand; and fashion beddings, tableware, eyewear, watches, stationery and gifts, and tech accessories under the Kate Spade brand. It sells its products to consumers through a network of 958 Coach stores, 420 Kate Spade stores, and 131 Stuart Weitzman stores, including the Internet and concession shop-in-shops; and wholesale customers, as well as through independent third party distributors. The company was formerly known as Coach, Inc. and changed its name to Tapestry, Inc. in October 2017. Tapestry, Inc. was founded in 1941 and is headquartered in New York, New York.
Advisors' Opinion:- [By Leo Sun]
It might seem risky to invest in a luxury goods maker when the bears expect a recession within the next two years. However, the highest-end brands are generally more resistant to economic downturns than mid-range "affordable luxury" brands like Tapestry's (NYSE:TPR) Coach and Kate Spade. That's why we recently saw Tapestry's stock plunge after it reported less than 1% sales growth last quarter.
- [By Motley Fool Transcribers]
Tapestry, Inc. (NYSE:TPR)Q2 2019 Earnings Conference CallFeb. 07, 2019, 8:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Chris Lange]
The S&P 500 stock posting the largest daily percentage loss ahead of the close was Tapestry, Inc. (NYSE: TPR) which traded down about 15% at $33.50. The stock's 52-week range is $31.91 to $55.50. Volume was 22.5 million compared to the daily average volume of 3.7 million.
Top Financial Stocks For 2022: AMAG Pharmaceuticals, Inc.(AMAG)
AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units. In addition, it has a license agreement with Velo to acquire the rights to digoxin immune fab, a polyclonal antibody in clinical development for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) – Analysts at Cantor Fitzgerald decreased their FY2019 EPS estimates for AMAG Pharmaceuticals in a research note issued on Tuesday, February 12th. Cantor Fitzgerald analyst M. Lillis now expects that the specialty pharmaceutical company will post earnings per share of ($1.56) for the year, down from their prior estimate of ($1.41). Cantor Fitzgerald has a “Neutral” rating on the stock. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) – Investment analysts at Piper Jaffray Companies issued their Q1 2020 earnings per share (EPS) estimates for shares of AMAG Pharmaceuticals in a research report issued on Thursday, February 7th. Piper Jaffray Companies analyst C. Raymond anticipates that the specialty pharmaceutical company will earn ($0.68) per share for the quarter. Piper Jaffray Companies also issued estimates for AMAG Pharmaceuticals’ Q2 2020 earnings at ($0.74) EPS, Q3 2020 earnings at ($0.77) EPS and Q4 2020 earnings at ($0.74) EPS. ING Clarion Global Real Estate Income Fund (the Fund) is a non-diversified, closed-end management investment company. The Fund's investments will be concentrated in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by companies deriving the majority of their revenue from the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real estate. The Fund will invest substantially all but no less than 80% of its total assets in income-producing real estate securities (including real estate investment trusts (REITs)) located mainly in the developed markets of North America, Europe, Australia and Asia. The Fund can invest up to 25% of its assets in preferred shares of global real estate companies. The Fund invests in various property types, including office, retail, diversified, apartments, industrials, hotels, healthcare and storage. ING Clarion Real Estate Securities, L.P. serves as the Fund's investment advisor. IG Design Group PLC (LON:IGR) insider S Anders Hedlund sold 500,000 shares of the stock in a transaction that occurred on Wednesday, September 19th. The shares were sold at an average price of GBX 510 ($6.64), for a total transaction of £2,550,000 ($3,321,610.00). CBRE Clarion Global Real Estate Income Fund (NYSE: IGR)Top Financial Stocks For 2022: CBRE Clarion Global Real Estate Income Fund(IGR)
A long time StreetAuthority staple, mainly in the Daily Paycheck portfolio, IGR is considered a core real estate fund. As the "global" in its name implies, the fund takes a broad approach, with just 41% of the fund's holdings allocated to U.S. REITs. Property-type diversification is also broad with just a 24% allocation to the worrisome retail sector. Shares trade at a nearly 12% discount to their net asset value (NAV) at around $7.80 with a yield approaching 7.7%.
No comments:
Post a Comment